May 30, 2018
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $14.92 to $746.00.
The split itself did not change the total investment value.
Oxford BioMedica plc (LSE:OXB) operates in the Biotechnology industry.
Oxford BioMedica plc company overviewOxford BioMedica plc's most recent stock split was on May 30, 2018. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
Oxford BioMedica plc (LSE:OXB) has split its stock 6 times: a 155-for-144 split on March 25, 1998, a 36-for-35 split on March 4, 1999, a 19-for-18 split on October 3, 2003, a 295-for-292 split on November 16, 2005, a 77-for-73 split on December 14, 2010, and a 1-for-50 reverse split on May 30, 2018.
Oxford BioMedica plc has split its stock 6 times. This history records 6 splits between March 25, 1998 and May 30, 2018.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Oxford BioMedica plc's 1-for-50 reverse split on May 30, 2018, every 50 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Oxford BioMedica plc has not announced a new split in our records. Its most recent split was on May 30, 2018, 8 years ago. Companies announce splits in advance, and any new LSE:OXB split will appear on this page.
Already premium?